NSVGF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
May 20 closing price
Capitalization
4.72M
SHPMY
Price
$8.00
Change
+$0.52 (+6.95%)
Updated
Jul 25 closing price
Capitalization
9.5B
Interact to see
Advertisement

NSVGF vs SHPMY

Header iconNSVGF vs SHPMY Comparison
Open Charts NSVGF vs SHPMYBanner chart's image
Nass Vy Gateway
Price$0.01
Change-$0.00 (-0.00%)
Volume$34.5K
Capitalization4.72M
Shanghai Pharmaceuticals Holdings
Price$8.00
Change+$0.52 (+6.95%)
Volume$158
Capitalization9.5B
NSVGF vs SHPMY Comparison Chart in %
Loading...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NSVGF vs. SHPMY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSVGF is a Hold and SHPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NSVGF: $0.01 vs. SHPMY: $8.00)
Brand notoriety: NSVGF and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: NSVGF: 100% vs. SHPMY: 38%
Market capitalization -- NSVGF: $4.72M vs. SHPMY: $9.5B
NSVGF [@Medical Distributors] is valued at $4.72M. SHPMY’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NSVGF’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • NSVGF’s FA Score: 0 green, 5 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than NSVGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHPMY’s TA Score shows that 2 TA indicator(s) are bullish.

  • SHPMY’s TA Score: 2 bullish, 3 bearish.

Price Growth

NSVGF (@Medical Distributors) experienced а 0.00% price change this week, while SHPMY (@Medical Distributors) price change was +9.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.49%. For the same industry, the average monthly price growth was +10.91%, and the average quarterly price growth was +3.82%.

Industries' Descriptions

@Medical Distributors (+3.49% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMY($9.5B) has a higher market cap than NSVGF($4.72M). NSVGF YTD gains are higher at: 0.000 vs. SHPMY (-1.350). SHPMY has higher annual earnings (EBITDA): 11.1B vs. NSVGF (-1.57M). SHPMY has higher revenues than NSVGF: SHPMY (241B) vs NSVGF (29.5K).
NSVGFSHPMYNSVGF / SHPMY
Capitalization4.72M9.5B0%
EBITDA-1.57M11.1B-0%
Gain YTD0.000-1.350-
P/E RatioN/A8.39-
Revenue29.5K241B0%
Total Cash0N/A-
Total Debt1.24MN/A-
FUNDAMENTALS RATINGS
NSVGF vs SHPMY: Fundamental Ratings
NSVGF
SHPMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
7944
P/E GROWTH RATING
1..100
10069
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMY's Valuation (62) in the null industry is in the same range as NSVGF (91). This means that SHPMY’s stock grew similarly to NSVGF’s over the last 12 months.

SHPMY's Profit vs Risk Rating (80) in the null industry is in the same range as NSVGF (100). This means that SHPMY’s stock grew similarly to NSVGF’s over the last 12 months.

SHPMY's SMR Rating (80) in the null industry is in the same range as NSVGF (100). This means that SHPMY’s stock grew similarly to NSVGF’s over the last 12 months.

SHPMY's Price Growth Rating (44) in the null industry is somewhat better than the same rating for NSVGF (79). This means that SHPMY’s stock grew somewhat faster than NSVGF’s over the last 12 months.

SHPMY's P/E Growth Rating (69) in the null industry is in the same range as NSVGF (100). This means that SHPMY’s stock grew similarly to NSVGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NSVGFSHPMY
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
57%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTST18.390.40
+2.22%
NetSTREIT Corp
CZNC19.220.04
+0.21%
Citizens & Northern Corp
MU111.26-0.47
-0.42%
Micron Technology
LTBR14.76-0.19
-1.27%
Lightbridge Corp
ADT8.44-0.23
-2.65%
ADT

NSVGF and

Correlation & Price change

A.I.dvisor tells us that NSVGF and PDRX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSVGF and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSVGF
1D Price
Change %
NSVGF100%
N/A
PDRX - NSVGF
8%
Poorly correlated
N/A
SHPMY - NSVGF
4%
Poorly correlated
+9.93%
SHTDF - NSVGF
4%
Poorly correlated
N/A
MAHLY - NSVGF
2%
Poorly correlated
N/A
AMFPF - NSVGF
0%
Poorly correlated
N/A
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and PDRX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and PDRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
+9.93%
PDRX - SHPMY
8%
Poorly correlated
N/A
ZYXI - SHPMY
5%
Poorly correlated
+1.98%
NSVGF - SHPMY
4%
Poorly correlated
N/A
SHTDF - SHPMY
3%
Poorly correlated
N/A
MEPDF - SHPMY
-3%
Poorly correlated
N/A
More